Cited by 2,351Regulation of Appetite and ObesityNeuropeptides and Animal PhysiologyHypothalamic control of reproductive hormones

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Gut hormone PYY3-36 physiologically inhibits food intake

Batterham, Rachel L., Cowley, Michael A., Small, Caroline J., Herzog, Herbert, Cohen, Mark A., Dakin, Catherine L., Wren, Alison M., Brynes, Audrey E., Low, Malcolm J., Ghatei, Mohammad A., Cone, Roger D., Bloom, Stephen R.·2002·Nature

DOI 10.1038/nature00887

Open this paper in CoChat — free account

Abstract

Food intake is regulated by the hypothalamus, including the melanocortin and neuropeptide Y (NPY) systems in the arcuate nucleus. The NPY Y2 receptor (Y2R), a putative inhibitory presynaptic receptor, is highly expressed on NPY neurons in the arcuate nucleus, which is accessible to peripheral hormones. Peptide YY(3-36) (PYY(3-36)), a Y2R agonist, is released from the gastrointestinal tract postprandially in proportion to the calorie content of a meal. Here we show that peripheral injection of PYY(3-36) in rats inhibits food intake and reduces weight gain. PYY(3-36) also inhibits food intake in mice but not in Y2r-null mice, which suggests that the anorectic effect requires the Y2R. Peripheral administration of PYY(3-36) increases c-Fos immunoreactivity in the arcuate nucleus and decreases hypothalamic Npy messenger RNA. Intra-arcuate injection of PYY(3-36) inhibits food intake. PYY(3-36) also inhibits electrical activity of NPY nerve terminals, thus activating adjacent pro-opiomelanocortin (POMC) neurons. In humans, infusion of normal postprandial concentrations of PYY(3-36) significantly decreases appetite and reduces food intake by 33% over 24 h. Thus, postprandial elevation of PYY(3-36) may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.

Integrity signals

Registry

Crossref · 10.1038/nature00887

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
Self-citation
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horváth, T. L., & Kalra, P. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.1.0357 · Cited by 1,564
Human distribution and release of a putative new gut hormone, peptide YY
Adrian, T. E., Ferri, G., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., & Bloom, S. R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90211-2 · Cited by 1,064
Self-citation
Genetics of body-weight regulation
Barsh, G. S., Farooqi, I. S., & O’Rahilly, S. (2000) · Nature · doi:10.1038/35007519 · Cited by 783
c-Fos and Related Immediate Early Gene Products as Markers of Activity in Neuroendocrine Systems
Hoffman, G. E., Smith, M. S., & Verbalis, J. G. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1006 · Cited by 715
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
Edwards, C. M. B., Stanley, S. A., Davis, R. P., Brynes, A. E., Frost, G. S., Seal, L., Ghatei, M. A., & Bloom, S. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e155 · Cited by 468
Self-citation
Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36
Grandt, D., Schimiczek, M., Beglinger, C., Layer, P., Goebell, H., Eysselein, V. E., & Reeve, J. R. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90204-6 · Cited by 363

Show all 25 references

Sorted by citations

Items 501–600 of 1,006

Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models
Forbes, S. C., Stafford, S., Coope, G., Heffron, H., Real, K., Newman, R., Davenport, R., Barnes, M., Grosse, J., & Cox, H. M. (2015) · Diabetes · doi:10.2337/db15-0481 · Cited by 85
Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival
Khan, D., Vasu, S., Moffett, R. C., Irwin, N., & Flatt, P. R. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.020 · Cited by 85
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
Deacon, C. F. (2018) · Peptides · doi:10.1016/j.peptides.2017.10.011 · Cited by 85
The Role of Oxidative Stress and Hormones in Controlling Obesity
Domenico, M. D., Pinto, F., Quagliuolo, L., Contaldo, M., Settembre, G., Romano, A., Coppola, M., Ferati, K., Bexheti‐Ferati, A., Sciarra, A., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00540 · Cited by 84
The Role of the Gut Microbiota in the Gut–Brain Axis in Obesity: Mechanisms and Future Implications
van Son, J., Koekkoek, L. L., la Fleur, S. E., Serlie, M. J. M., & Nieuwdorp, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062993 · Cited by 85
Pharmacological Approaches to Weight Reduction: Therapeutic Targets
Körner, J., & Aronne, L. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0341 · Cited by 84
The role of oxyntomodulin and peptide tyrosine–tyrosine (PYY) in appetite control
Wynne, K., & Bloom, S. R. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0318 · Cited by 84
Self-citation
Peptide YY and appetite control
McGowan, B. M., & Bloom, S. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.06.007 · Cited by 84
Self-citation
Leveraging the Gut to Treat Metabolic Disease
Gimeno, R. E., Briere, D. A., & Seeley, R. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.014 · Cited by 84
Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY
Unniappan, S., McIntosh, C. H. S., Demuth, H. U., Heiser, U. F., Wolf, R., & Kieffer, T. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0310-8 · Cited by 83
Long-Acting Lipidated Analogue of Human Pancreatic Polypeptide Is Slowly Released into Circulation
Bellmann‐Sickert, K., Elling, C., Madsen, A. N., Little, P. B., Lundgren, K., Gerlach, L., Bergmann, R., Holst, B., Schwartz, T. W., & Beck‐Sickinger, A. G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101357e · Cited by 83
Neurophysiology of hunger and satiety
Smith, P., & Ferguson, A. V. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.13 · Cited by 82
Food-grade micro-encapsulation systems that may induce satiety via delayed lipolysis: A review
Corstens, M. N., Berton‐Carabin, C., de Vries, R. J., Troost, F. J., Masclee, A., & Schroën, K. G. P. H. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1057634 · Cited by 82
Neuropeptide Y Y2 receptor in health and disease
Parker, S. L., & Balasubramaniam, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707445 · Cited by 82
Molecular characterization, appetite regulatory effects and feeding related changes of peptide YY in goldfish
Gonzalez, R., & Unniappan, S. (2009) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2009.09.008 · Cited by 82
Peptide YY Regulates Bone Turnover in Rodents
Wortley, K. E., García, K., Okamoto, H., Thabet, K., Anderson, K. D., Shen, V., Herman, J. P., Valenzuela, D. M., Yancopoulos, G. D., Tschöp, M. H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.024 · Cited by 82
Physical Activity and Hormonal Regulation of Appetite
Hagobian, T. A., & Braun, B. (2009) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3181c5cd98 · Cited by 82
The droplet size of intraduodenal fat emulsions influences antropyloroduodenal motility, hormone release, and appetite in healthy males
Seimon, R. V., Wooster, T. J., Otto, B., Golding, M., Day, L., Little, T. J., Horowitz, M., Clifton, P. M., & Feinle‐Bisset, C. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27518 · Cited by 82
Gastric leptin: a putative role in the short-term regulation of food intake
Picó, C., Oliver, P., Sánchez, J., & Palou, A. (2003) · British Journal Of Nutrition · doi:10.1079/bjn2003945 · Cited by 82
Role of brain-gut-muscle axis in human health and energy homeostasis
Yin, Y., Guo, Q., Zhou, X., Duan, Y., Yang, Y., Gong, S., Han, M., Liu, Y., Yang, Z., Chen, Q., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.947033 · Cited by 81
Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists
Finan, B., Clemmensen, C., & Müller, T. D. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.07.003 · Cited by 81
Peptide YY and Glucagon-like Peptide-1 in Morbidly Obese Patients Before and After Surgically Induced Weight Loss
Reinehr, T., Roth, C. L., Schernthaner, G.-H., Kopp, H.-P., Kriwanek, S., & Schernthaner, G. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9323-8 · Cited by 81
Gut Peptide Signaling in the Controls of Food Intake
Moran, T. H. (2006) · Obesity · doi:10.1038/oby.2006.318 · Cited by 81
The Neuroendocrine Basis of Anorexia Nervosa and Its Impact on Bone Metabolism
Misra, M., & Klibanski, A. (2011) · Neuroendocrinology · doi:10.1159/000323771 · Cited by 81
Different Effect of Laparoscopic Roux-en-Y Gastric Bypass and Open Biliopancreatic Diversion of Scopinaro on Serum PYY and Ghrelin Levels
García‐Fuentes, E., Garrido‐Sánchez, L., García‐Almeida, J. M., García-Arnés, J. A., Gallego-Perales, J. L., Rivas-Marín, J., Morcillo, S., Cardona, I., & Soriguer, F. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9560-5 · Cited by 81
The gut–brain axis in obesity
Buhmann, H., le Roux, C. W., & Bueter, M. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.003 · Cited by 81
Importance of Melanocortin Signaling in Refeeding-Induced Neuronal Activation and Satiety
Singru, P. S., Sánchez, E., Fekete, C., & Lechan, R. M. (2006) · Endocrinology · doi:10.1210/en.2006-1233 · Cited by 81
Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemma
Steiner, J. H., Bernstein, H., Schiltz, K., Müller, U., Westphal, S., Drexhage, H. A., & Bogerts, B. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.016 · Cited by 81
Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study
Alamuddin, N., Vetter, M. L., Ahima, R. S., Hesson, L. A., Ritter, S., Minnick, A. M., Faulconbridge, L. F., Allison, K. C., Sarwer, D. B., Chittams, J. L., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2505-5 · Cited by 81
Regulation of body weight: Lessons learned from bariatric surgery
Albaugh, V. L., He, Y., Münzberg, H., Morrison, C. D., Yu, S., & Berthoud, H. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101517 · Cited by 80
Oral glucose intake inhibits hypothalamic neuronal activity more effectively than glucose infusion
Smeets, P. A. M., Vidarsdóttir, S., de Graaf, C., Stafleu, A., van Osch, M. J. P., Viergever, M. A., Pijl, H., & van der Grond, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00231.2007 · Cited by 80
Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader–Willi syndrome
Waele, K. D., Ishkanian, S. L., Bogarin, R., Miranda, C. A., Ghatei, M. A., Bloom, S. R., Pacaud, D., & Chanoine, J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0462 · Cited by 80
Self-citation
Irregular meal-pattern effects on energy expenditure, metabolism, and appetite regulation: a randomized controlled trial in healthy normal-weight women
Alhussain, M. H., Macdonald, I. A., & Taylor, M. A. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.125401 · Cited by 80
Energy homeostasis and cachexia in chronic kidney disease
MAK, R. H. K., & Cheung, W. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0194-3 · Cited by 80
NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting
Segal‐Lieberman, G., Trombly, D. J., Juthani, V. V., Wang, X., & Maratos–Flier, E. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2002 · Cited by 80
Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction
Minor, R. K., Chang, J. W., & de Cabo, R. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.044 · Cited by 79
Combination Therapy with Amylin and Peptide YY[3–36] in Obese Rodents: Anorexigenic Synergy and Weight Loss Additivity
Roth, J. D., Coffey, T. S., Jodka, C. M., Maier, H., Athanacio, J., Mack, C. M., Weyer, C., & Parkes, D. G. (2007) · Endocrinology · doi:10.1210/en.2007-0898 · Cited by 79
Role of CCK 1 and Y 2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands
Hao, S., Sternini, C., & Raybould, H. E. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00675.2007 · Cited by 79
Neuropeptide Y stimulates food intake and regulates metabolism in grass carp, Ctenopharyngodon idellus
Zhou, Y., Liang, X., Yuan, X., Li, J., He, Y., Liu, F., Guo, X., Liu, L., Li, B., & Shen, D. (2012) · Aquaculture · doi:10.1016/j.aquaculture.2012.11.033 · Cited by 79
Glucose Ingestion Fails to Inhibit Hypothalamic Neuronal Activity in Patients With Type 2 Diabetes
Vidarsdóttir, S., Smeets, P. A. M., Eichelsheim, D. L., van Osch, M. J. P., Viergever, M. A., Romijn, J. A., van der Grond, J., & Pijl, H. (2007) · Diabetes · doi:10.2337/db07-0193 · Cited by 79
Gut Hormones and Energy Balance, The Future for Obesity Therapy?
Meiliana, A., & Wijaya, A. (2009) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v1i3.99 · Cited by 79
The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders
Islam, M. R., Arthur, S., Haynes, J., Butts, M. R., Nepal, N., & Sundaram, U. (2022) · Nutrients · doi:10.3390/nu14030624 · Cited by 73
The versatility of the vagus
Dockray, G. J. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.01.009 · Cited by 78
Intravenous Peptide YY3‐36 and Y2 Receptor Antagonism in the Rat: Effects on Feeding Behaviour
Scott, V., Kimura, N., Stark, J. A., & Luckman, S. M. (2005) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01330.x · Cited by 78
Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy
Rosenstock, J., Cefalu, W. T., Lapuerta, P., Zambrowicz, B., Ogbaa, I., Banks, P. L., & Sands, A. (2014) · Diabetes Care · doi:10.2337/dc14-0890 · Cited by 78
Emerging therapeutic potential for peptide YY for obesity-diabetes
Lafferty, R. A., Flatt, P. R., & Irwin, N. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.005 · Cited by 78
Effect of Uncontrolled Diabetes on Plasma Ghrelin Concentrations and Ghrelin-Induced Feeding
Gelling, R. W., Overduin, J., Morrison, C. D., Morton, G. J., Frayo, R. S., Cummings, D. E., & Schwartz, M. W. (2004) · Endocrinology · doi:10.1210/en.2004-0605 · Cited by 78
Pharmacogenetics of antipsychotic-induced weight gain
Müller, D. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.05.001 · Cited by 78
Overview of human obesity and central mechanisms regulating energy homeostasis
Crowley, V. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2007.007193 · Cited by 78
The incretin/glucagon system as a target for pharmacotherapy of obesity
Del Prato, S., Gallwitz, B., Holst, J. J., & Meier, J. J. (2022) · Obesity Reviews · doi:10.1111/obr.13372 · Cited by 77
The role of peptide YY in regulating glucose homeostasis
Boey, D., Sainsbury, A., & Herzog, H. (2007) · Peptides · doi:10.1016/j.peptides.2006.07.031 · Cited by 77
Self-citation
Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter‐related molecules
Stanić, D., Mulder, J., Watanabe, M., & Hökfelt, T. G. M. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22608 · Cited by 77
Factors affecting circulating levels of peptide YY in humans: a comprehensive review
Cooper, J. A. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000109 · Cited by 77
New approaches to the pharmacological treatment of obesity: Can they break through the efficacy barrier?
Kennett, G. A., & Clifton, P. G. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.07.020 · Cited by 77
The effects of short-chain fatty acids on the cardiovascular system
Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J., & Folkerts, G. (2016) · PharmaNutrition · doi:10.1016/j.phanu.2016.02.001 · Cited by 77
Obesity, body weight regulation and the brain: insights from fMRI
Makaronidis, J., & Batterham, R. L. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170910 · Cited by 77
Self-citation
The Role of Neuropeptide Y and Peptide YY in the Development of Obesity via Gut-brain Axis
Wu, Y., He, H., Cheng, Z., Bai, Y., & Ma, X. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190125105401 · Cited by 77
The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat
Abbott, C. R., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R. C., Broadhead, L. L., Ghatei, M. A., & Bloom, S. R. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803137 · Cited by 77
Self-citation
Behavioral neuroendocrinology and treatment of anorexia nervosa
Södersten, P., Nergårdh, R., Bergh, C. E. K., Zandian, M., & Scheurink, A. J. W. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.06.001 · Cited by 76
Mechanistic relationship between the vagal afferent pathway, central nervous system and peripheral organs in appetite regulation
Ueno, H., & Nakazato, M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12492 · Cited by 76
A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice
Ishihara, A., Kanatani, A., Mashiko, S., Tanaka, T., Hidaka, M., Gomori, A., Iwaasa, H., Murai, N., Egashira, S., Murai, T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510320103 · Cited by 76
Impact of nutrition on canine behaviour: current status and possible mechanisms
Bosch, G., Beerda, B., Hendriks, W. H., van der Poel, A. F. B., & Verstegen, M. W. A. (2007) · Nutrition Research Reviews · doi:10.1017/s095442240781331x · Cited by 75
Postprandial changes in gut regulatory peptides in gastric bypass patients
Holdstock, C., Zethelius, B., Sundbom, M., Karlsson, F. A., & Engström, B. E. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.157 · Cited by 75
Chronic PYY3–36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice
van den Hoek, A. M., Heijboer, A. C., Voshol, P. J., Havekes, L. M., Romijn, J. A., Corssmit, E. P. M., & Pijl, H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00239.2006 · Cited by 75
Neuropeptides at the crossroad of fear and hunger: a special focus on neuropeptide Y
Comeras, L. B., Herzog, H., & Tasan, R. O. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14179 · Cited by 72
Self-citation
Anabolic neuropeptides
Williams, G. H., Cai, X., Elliott, J. C., & Harrold, J. A. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.02.005 · Cited by 75
Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature
Chen, Y.-K., Liu, T.-T., Teia, F. K. F., & Xie, M.-Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1218880 · Cited by 74
Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity
Gan, H., Cerbone, M., & Dattani, M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad033 · Cited by 75
The use of the reinstatement model to study relapse to palatable food seeking during dieting
Calu, D. J., Chen, Y., Kawa, A. B., Nair, S. G., & Shaham, Y. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.030 · Cited by 74
Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man
Witte, A.-B., Grybäck, P., Holst, J. J., Hilsted, L., Hellström, P. M., Jacobsson, H., & Schmidt, P. T. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.07.013 · Cited by 74
The role of the vagus nerve in appetite control: Implications for the pathogenesis of obesity
Cork, S. C. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12643 · Cited by 74
Modulation of neuropeptide Y expression in adult mice does not affect feeding
Marie, L. S., Luquet, S. H., Cole, T. B., & Palmiter, R. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509240102 · Cited by 74
Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis
Thorens, B., & Larsen, P. J. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000134368.91900.84 · Cited by 73
CCK, PYY and PP: The Control of Energy Balance
Simpson, K. A., Parker, J., Plumer, J., & Bloom, S. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_9 · Cited by 73
Self-citation
Effects of Peripherally Administered Neuromedin U on Energy and Glucose Homeostasis
Peier, A. M., Desai, K., Hubert, J. A., Du, X., Yang, L., Qian, Y., Kosinski, J. R., Metzger, J. M., Pocai, A., Nawrocki, A. R., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1463 · Cited by 73
The central nervous system at the core of the regulation of energy homeostasis
Magnan, C. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s37 · Cited by 73
PYY(3–36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats
Blevins, J. E., Chelikani, P. K., Haver, A. C., & Reidelberger, R. D. (2007) · Peptides · doi:10.1016/j.peptides.2007.11.003 · Cited by 73
CNS-targets in control of energy and glucose homeostasis
Kleinridders, A., Könner, A. C., & Brüning, J. C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.10.006 · Cited by 74
PYY3–36 inhibits the action potential firing activity of POMC neurons of arcuate nucleus through postsynaptic Y2 receptors
Ghamari‐Langroudi, M., Colmers, W. F., & Cone, R. D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.003 · Cited by 73
Self-citation
Metabolic Effects of Resistant Starch Type 2: A Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials
Snelson, M., Jong, J., Manolas, D., Kok, S., Louise, A., Stern, R., & Kellow, N. J. (2019) · Nutrients · doi:10.3390/nu11081833 · Cited by 73
Load-dependent effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men
Pilichiewicz, A. N., Papadopoulos, P., Brennan, I. M., Little, T. J., Meyer, J. H., Wishart, J. M., Horowitz, M., & Feinle‐Bisset, C. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00511.2007 · Cited by 72
Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy
Papamargaritis, D., le Roux, C. W., Sioka, E., KOUKOULIS, G. N., Tzovaras, G. A., & Zacharoulis, D. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.08.007 · Cited by 72
The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism
Mells, J. E., & Anania, F. A. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1358527 · Cited by 72
Brain imaging studies of appetite in the context of obesity and the menstrual cycle
Vugt, D. A. V. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp051 · Cited by 72
Prokineticin 2 Is a Hypothalamic Neuropeptide That Potently Inhibits Food Intake
Gardiner, J., Bataveljic, A., Patel, N. A., Bewick, G. A., Roy, D., Campbell, D., Greenwood, H. C., Murphy, K. G., Hameed, S., Jethwa, P. H., et al. (2009) · Diabetes · doi:10.2337/db09-1198 · Cited by 72
Self-citation
Intestinal GLP-1 and satiation: from man to rodents and back
Steinert, R. E., Beglinger, C., & Langhans, W. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.172 · Cited by 72
Neuroendocrine regulation of eating behavior
Vettor, R., Fabris, R., Pagano, C., & Federspil, G. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344047 · Cited by 72
Characterization of neuropeptide F and its receptor from the African malaria mosquito, Anopheles gambiae
Garczynski, S. F., CRIM, J. W., & Brown, M. R. (2004) · Peptides · doi:10.1016/j.peptides.2004.07.014 · Cited by 72
The Regulation of Peripheral Metabolism by Gut-Derived Hormones
Sun, E. W. L., Martin, A. M., Young, R. L., & Keating, D. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00754 · Cited by 71
The role of peptide YY in gastrointestinal diseases and disorders
El‐Salhy, M., Mazzawi, T. R. E., Gundersen, D., Hatlebakk, J. G., & Hausken, T. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1222 · Cited by 71
GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior
Samms, R. J., Cosgrove, R., Snider, B. M., Furber, E. C., Droz, B. A., Briere, D. A., Dunbar, J. D., Dogra, M., Alsina‐Fernandez, J., Borner, T., et al. (2022) · Diabetes · doi:10.2337/db21-0848 · Cited by 71
Mechanisms of Disease: the role of gastrointestinal hormones in appetite and obesity
Vincent, R. P., Ashrafian, H., & le Roux, C. W. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1118 · Cited by 71
Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats
Guijarro, A. I., Suzuki, S., Chen, C., Kirchner, H., Middleton, F. A., Nadtochiy, S. M., Brookes, P. S., Niijima, A., Inui, A., & Meguid, M. M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00171.2007 · Cited by 71
Alcohol‐Induced Disruption of Endocrine Signaling
Ronis, M. J. J., Wands, J. R., Badger, T. M., de la Monte, S. M., Lang, C. H., & Calissendorff, J. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00436.x · Cited by 71
Can Gut Hormones Control Appetite and Prevent Obesity?
Chaudhri, O. B., Wynne, K., & Bloom, S. R. (2008) · Diabetes Care · doi:10.2337/dc08-s269 · Cited by 71
Self-citation
Neurohormonal Regulation of Appetite and its Relationship with Stress: A Mini Literature Review
Ans, A. H., Anjum, I., Satija, V., Inayat, A., Asghar, Z., Akram, I., & Shrestha, B. (2018) · Cureus · doi:10.7759/cureus.3032 · Cited by 71
Brain Circuits Regulating Energy Homeostasis
Horváth, T. L., Diano, S., & Tschöp, M. H. (2004) · The Neuroscientist · doi:10.1177/1073858403262151 · Cited by 71
Characterization and functional role of voltage gated cation conductances in the glucagon‐like peptide‐1 secreting GLUTag cell line
Reimann, F. M., Maziarz, M., Flock, G. B., Habib, A. M., Drucker, D. J., & Gribble, F. M. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.076414 · Cited by 71
Pharmacotherapy of obesity
Finer, N. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0231 · Cited by 71
Peptide hormones regulating appetite—focus on neuroimaging studies in humans
Schloegl, H., Percik, R., Horstmann, A., Villringer, A., & Stumvoll, M. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1154 · Cited by 70

Authors: Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., Cone, R. D., & Bloom, S. R.
Affiliations: Imperial College London (GB)
Oregon National Primate Research Center (US)
Garvan Institute of Medical Research (AU)
Oregon Health & Science University (US)
Corresponding author: Bloom, Stephen R.
ORCID: Batterham, Rachel L.
Cowley, Michael A.
Herzog, Herbert
Low, Malcolm J.
Cone, Roger D.
Bloom, Stephen R.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2002-08
Volume: 418
Issue: 6898
Pages: 650-654
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature00887
OpenAlex: W2091685843
Cited by: 2,351
References: 25
Citations by year: 2026: 54 · 2025: 64 · 2024: 55 · 2023: 53 · 2022: 73 · 2021: 106 · 2020: 73 · 2019: 92 · 2018: 97 · 2017: 70 · 2016: 73 · 2015: 98 · 2014: 97 · 2013: 121 · 2012: 121
FWCI: 38.36
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords: PYY3-36, food intake regulation, arcuate nucleus, hypothalamus, proopiomelanocortin neurons, postprandial satiety, appetite, weight gain, c-fos, NPY neurons
MeSH terms: Action Potentials, Animals, Appetite, Arcuate Nucleus of Hypothalamus, Body Weight, Energy Intake, Electrophysiology, Feeding Behavior, Humans, Injections, Intraperitoneal, Injections, Intraventricular, Male, Mice, Inbred C57BL, Neurons, Peptide Fragments, Pro-Opiomelanocortin, Signal Transduction, Proto-Oncogene Proteins c-fos, Rats, Wistar, Gene Deletion, Receptors, Neuropeptide Y, Mice, Knockout, Peptide YY, Leptin, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Gut hormone PYY3-36 physiologically inhibits food intake

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks